Cetuximab Monoclonal Antibody from Japan
Cetuximab (Erbitux) targets EGFR for colorectal and head/neck cancer therapy, a chimeric monoclonal antibody. Bulk unmixed form imports under HTS 3002.13.0010 as a biotech immunological product per chapter note definitions. Excludes retail or dosed packings.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Require DEA scheduling check if any narcotic analogs present (rare for monoclonals)
• Use ISF filings 24hrs prior with detailed biotech manufacturing specs
• Ensure no 'mixed' status per note 3(b) to stay in unmixed category